AbbVie Unveils New Data from Robust Gastroenterology Portfolio at the 19th Congress of European Crohn's and Colitis Organisation (ECCO)

– A total of 17 accepted abstracts, including nine oral presentations and eight posters, reinforce AbbVie's commitment to produce a portfolio of products that aim to improve the lives of patients...

Related Keywords

Chicago ,Illinois ,United States ,Sweden ,Stockholm ,Ohio ,Remo Panaccione ,Ann Gastroenterol ,Gastroenterol Hepatol ,International Medical Affairs ,Drug Administration ,University Of Calgary ,National Institute Of Diabetes ,Boehringer Ingelheim ,Youtube ,Facebook ,Exchange Commission ,Twitter ,Abbvie Inc ,Instagram ,Linkedin ,Crohn Colitis Foundation ,Colitis Organisation ,Abbvie Ltd ,European Medicines Agency ,Abbvie Deutschland Gmbh Co ,European Crohn ,Sofie Berg ,Inflammatory Bowel Disease ,Important Safety Information ,Medication Guide ,Consumer Brief Summary ,Pregnancy Registry ,Full Prescribing Information ,Mississippi River ,Allergan Aesthetics ,Private Securities Litigation Reform Act ,Quarterly Reports ,Published November ,Accessed June ,Accessed August ,Rev Gastroenterol ,Vie Deutschland Gmbh ,Placebo Controlled Induction Study ,Participants With Moderately ,Severely Active Ulcerative ,Markets ,